These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 17143271)
1. IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Russo SJ; Bolanos CA; Theobald DE; DeCarolis NA; Renthal W; Kumar A; Winstanley CA; Renthal NE; Wiley MD; Self DW; Russell DS; Neve RL; Eisch AJ; Nestler EJ Nat Neurosci; 2007 Jan; 10(1):93-9. PubMed ID: 17143271 [TBL] [Abstract][Full Text] [Related]
2. Tolerance to opiate reward: role of midbrain IRS2-Akt pathway. Harvey BK; Hope BT; Shaham Y Nat Neurosci; 2007 Jan; 10(1):9-10. PubMed ID: 17189943 [No Abstract] [Full Text] [Related]
3. Mesoaccumbens dopamine signaling alteration underlies behavioral transition from tolerance to sensitization to morphine rewarding properties during morphine withdrawal. Sun L; Hu L; Li Y; Cui C Brain Struct Funct; 2014 Sep; 219(5):1755-71. PubMed ID: 23775491 [TBL] [Abstract][Full Text] [Related]
4. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward. David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918 [TBL] [Abstract][Full Text] [Related]
5. CART peptide in the nucleus accumbens shell acts downstream to dopamine and mediates the reward and reinforcement actions of morphine. Upadhya MA; Nakhate KT; Kokare DM; Singh U; Singru PS; Subhedar NK Neuropharmacology; 2012 Mar; 62(4):1823-33. PubMed ID: 22186082 [TBL] [Abstract][Full Text] [Related]
6. Peripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats. Chu NN; Zuo YF; Meng L; Lee DY; Han JS; Cui CL Brain Res; 2007 Nov; 1182():90-8. PubMed ID: 17945205 [TBL] [Abstract][Full Text] [Related]
7. Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms. Zarrindast MR; Ebrahimi-Ghiri M; Rostami P; Rezayof A Behav Brain Res; 2007 Jul; 181(1):35-41. PubMed ID: 17451818 [TBL] [Abstract][Full Text] [Related]
8. NR2B subunit of NMDA receptor at nucleus accumbens is involved in morphine rewarding effect by siRNA study. Kao JH; Huang EY; Tao PL Drug Alcohol Depend; 2011 Nov; 118(2-3):366-74. PubMed ID: 21601998 [TBL] [Abstract][Full Text] [Related]
9. Implication of protein kinase C in the orexin-induced elevation of extracellular dopamine levels and its rewarding effect. Narita M; Nagumo Y; Miyatake M; Ikegami D; Kurahashi K; Suzuki T Eur J Neurosci; 2007 Mar; 25(5):1537-45. PubMed ID: 17425580 [TBL] [Abstract][Full Text] [Related]
10. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Borgkvist A; Usiello A; Greengard P; Fisone G Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906 [TBL] [Abstract][Full Text] [Related]
11. Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area. Esmaeili MH; Kermani M; Parvishan A; Haghparast A Behav Brain Res; 2012 May; 231(1):111-5. PubMed ID: 22426507 [TBL] [Abstract][Full Text] [Related]
12. Endogenous histamine inhibits the development of morphine-induced conditioned place preference. Gong YX; Lv M; Zhu YP; Zhu YY; Wei EQ; Shi H; Zeng QL; Chen Z Acta Pharmacol Sin; 2007 Jan; 28(1):10-8. PubMed ID: 17184577 [TBL] [Abstract][Full Text] [Related]
13. Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity. Kaplan GB; Leite-Morris KA; Klufas MA; Fan W Eur J Pharmacol; 2009 Jan; 602(2-3):268-76. PubMed ID: 19027733 [TBL] [Abstract][Full Text] [Related]
14. Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Morón JA; Gullapalli S; Taylor C; Gupta A; Gomes I; Devi LA Neuropsychopharmacology; 2010 Mar; 35(4):955-66. PubMed ID: 19956087 [TBL] [Abstract][Full Text] [Related]
15. Subsequently enhanced CPP to morphine following chronic but not acute footshock stress associated with corticosterone mechanism in rats. Li Y; Li GY; Li LJ; Wang CH; Li ZX; Zhang JL; Zhang J; Li WH Int J Neurosci; 2007 Sep; 117(9):1237-55. PubMed ID: 17654090 [TBL] [Abstract][Full Text] [Related]
16. A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice. Urs NM; Daigle TL; Caron MG Neuropsychopharmacology; 2011 Feb; 36(3):551-8. PubMed ID: 20980993 [TBL] [Abstract][Full Text] [Related]
17. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Sklair-Tavron L; Shi WX; Lane SB; Harris HW; Bunney BS; Nestler EJ Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11202-7. PubMed ID: 8855333 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic upregulation of PSD-95 contributes to the rewarding behavior by morphine conditioning. Wang Z; Yan P; Hui T; Zhang J Eur J Pharmacol; 2014 Jun; 732():123-9. PubMed ID: 24704371 [TBL] [Abstract][Full Text] [Related]
19. Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Mazei-Robison MS; Koo JW; Friedman AK; Lansink CS; Robison AJ; Vinish M; Krishnan V; Kim S; Siuta MA; Galli A; Niswender KD; Appasani R; Horvath MC; Neve RL; Worley PF; Snyder SH; Hurd YL; Cheer JF; Han MH; Russo SJ; Nestler EJ Neuron; 2011 Dec; 72(6):977-90. PubMed ID: 22196333 [TBL] [Abstract][Full Text] [Related]
20. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Borgland SL; Taha SA; Sarti F; Fields HL; Bonci A Neuron; 2006 Feb; 49(4):589-601. PubMed ID: 16476667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]